LBT 5.56% 1.7¢ lbt innovations limited

Ann: Presentation at 14th Bioshares Biotech Summit, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 119 Posts.
    lightbulb Created with Sketch. 21
    Being a Medical Scientist myself and experiencing the ever-changing world of Pathology and diagnostic testing, LBT is part of this advancing field of pathology. Microbiology is one of the last areas to embrace automation. When LBT begins selling these analysers the world of Microbiology will change forever. The ageing population and increased resistance to antibiotics means an increase in the demand for diagnostic testing and quicker turnaround times.
    Simply put, pathology (especially microbiology) needs to embrace innovation and change, otherwise the ever increasing demand and pressure for quicker and more accurate diagnostic testing will NEVER be met if we don't embrace this essential change. The future of Pathology depends on keeping up and ahead of technology.
    LBT is revolutionising microbiology! The demand for automation and increased diagnostic testing is only going to increase in the future! A win win for LBT.
 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $23.13M
Open High Low Value Volume
1.8¢ 1.8¢ 1.7¢ $13.20K 747.0K

Buyers (Bids)

No. Vol. Price($)
4 776749 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 238095 1
View Market Depth
Last trade - 16.10pm 26/11/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.